Oppenheimer & Co. Inc. reduced its position in Alcentra Capital Corp (NASDAQ:ABDC) by 16.2% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,862 shares of the asset manager’s stock after selling 5,395 shares during the period. Oppenheimer & Co. Inc. owned about 0.22% of Alcentra Capital worth $233,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Acadian Asset Management LLC increased its stake in Alcentra Capital by 40.8% in the 2nd quarter. Acadian Asset Management LLC now owns 17,196 shares of the asset manager’s stock valued at $145,000 after purchasing an additional 4,985 shares in the last quarter. Appleton Partners Inc. MA purchased a new position in Alcentra Capital in the 2nd quarter valued at approximately $89,000. Pacific Ridge Capital Partners LLC increased its position in Alcentra Capital by 1.5% during the first quarter. Pacific Ridge Capital Partners LLC now owns 445,952 shares of the asset manager’s stock worth $3,345,000 after buying an additional 6,794 shares in the last quarter. Globeflex Capital L P increased its position in Alcentra Capital by 18.5% during the first quarter. Globeflex Capital L P now owns 127,838 shares of the asset manager’s stock worth $959,000 after buying an additional 19,932 shares in the last quarter. Finally, LSV Asset Management increased its position in Alcentra Capital by 1,814.8% during the first quarter. LSV Asset Management now owns 39,540 shares of the asset manager’s stock worth $296,000 after buying an additional 37,475 shares in the last quarter. 38.31% of the stock is owned by hedge funds and other institutional investors.
Alcentra Capital stock remained flat at $$8.91 during mid-day trading on Friday. The company’s stock had a trading volume of 298 shares, compared to its average volume of 89,591. The firm has a 50-day moving average price of $8.67 and a 200 day moving average price of $8.22. The firm has a market cap of $114.76 million, a P/E ratio of 8.82 and a beta of 0.54. Alcentra Capital Corp has a one year low of $5.58 and a one year high of $9.40.
Alcentra Capital (NASDAQ:ABDC) last released its quarterly earnings results on Wednesday, August 7th. The asset manager reported $0.20 earnings per share for the quarter, hitting the consensus estimate of $0.20. The company had revenue of $6.14 million during the quarter, compared to the consensus estimate of $6.11 million. Alcentra Capital had a return on equity of 8.30% and a net margin of 31.91%. On average, research analysts anticipate that Alcentra Capital Corp will post 0.8 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, October 3rd. Shareholders of record on Thursday, September 26th will be given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 8.08%. The ex-dividend date is Wednesday, September 25th. Alcentra Capital’s payout ratio is 71.29%.
Separately, ValuEngine downgraded Alcentra Capital from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st.
Alcentra Capital Profile
Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and oil and gas services sector.
Recommended Story: How prevalent are 12b-1 fees?
Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.